Integration of FDG- PET/CT into external beam radiation therapy planning: Technical aspects and recommendations on methodologica l approaches;Integration der FDG-PET/CT-Bildgebung in die Planung der externen Strahlentherapie - Technische Aspekte und Empfehlungen zur methodischen Annäherung

NuklearMedizin

Volumn 51, Issue 4, 2012, Pages 140-153

  Thorwarth, D ^a   Beyer, T ^b,c   Boellaard, R ^d   De Ruysscher, D ^e   Grgic, A ^f   Lee, J A ^g   Pietrzyk, U ^h,i   Sattler, B ^j   Schaefer, A ^f   van Elmpt, W ^e   Vogel, W ^k   Oyen, W J G ^l   Nestle, U ^m  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Visceral and Transplant Surgery   (Germany)

^c Cmi experts   (Switzerland)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f SAARLAND UNIVERSITY   (Germany)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h FORSCHUNGSZENTRUM JÜLICH   (Germany)

ⁱ UNIVERSITY OF WUPPERTAL   (Germany)

^j UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^k NETHERLANDS CANCER INSTITUTE   (Netherlands)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

FDG; PET CT; Radiation therapy planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LUTETIUM; SILICATE;

BREATHING PATTERN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE RECONSTRUCTION; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT CARE; PATIENT POSITIONING; QUALITY CONTROL; RESPIRATORY GATED IMAGING; REVIEW; SIGNAL NOISE RATIO; STAFF TRAINING; STANDARDIZATION; TREATMENT PLANNING; WORKFLOW;

ALGORITHMS; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, IMAGE-GUIDED; SYSTEMS INTEGRATION;

EID: 84866449569     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0455-11-12     Document Type: Review

References (90)

1. Balter JM, Cao Y. Advanced technologies in imageguided radiation therapy. Semin Radiat Oncol 2007; 17: 293-297.
2. Balter JM, Kessler ML. Imaging and alignment for image-guided radiation therapy. J Clin Oncol 2007; 25: 931-937.
3. Bayne M, Hicks RJ, Everitt S et al. Reproducibility of "intelligent" contouring of gross tumour volume in non-small-cell lung cancer on PET/CT images using a standardized visual method. Int J Radiat Oncol Biol Phys 2010; 77: 1151-1157.
4. Beddar AS, Briere TM, Balter P et al. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumours for treatment planning. Radiother Oncol 2008; 87: 445-448.
5. Bendriem B, Townsend DW (eds). The Theory and Practice of 3D PET. Developments in Nuclear Medicine (Vol 32). Kluwer Academic Publishers 1998.
6. Bettinardi V, Picchio M, Di Muzio N et al. Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques. Radiother Oncol 2010; 96: 311-316.
7. Beyer T, Antoch G, Müller S et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004; 45 (Suppl 1): 25S-35S.
8. Beyer T, Bockisch A, Kuhl H et al. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts. J Nucl Med 2006; 47: 91-99.
9. Beyer T, Tellmann L, Nickel I et al. On the use of positioning aids to reduce misregistration in the head and neck in whole-body PET/CT studies. J Nucl Med 2005; 46: 596-602.
10. Bockisch A, Beyer T, Antoch G et al. Positron emission tomography/computed tomography-- imaging protocols, artifacts, and pitfalls. Mol Imaging Biol 2004; 6: 188-199.
11. Boellaard R, Krak NC, Hoekstra OS et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004; 45: 1519-1527.
12. Boellaard R, O'Doherty MJ, Weber WA et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010; 37: 181-200.
13. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009; 50 (Suppl 1): 11S-20S.
14. Brechtel K, Heners H, Mueller M et al. Fixation devices for whole-body 18F-FDG PET/CT: patient perspectives and technical aspects. Nucl Med Commun 2007; 28: 141-147.
15. Busemann Sokole E, Plachcínska A, Britten A. Acceptance testing for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging 2010; 37: 672-681.
16. Busemann Sokole E, Placinska A, Britten A et al. Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging 2010; 37: 662-671.
17. Caldwell CB, Mah D, Ung YC et al. Observer variation in contouring gross tumour volume in patients with poorly defined non-small-cell lung tumours on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001; 51: 923-931.
18. Chiti A, Kirienko M, Grégoire V. Clinical use of PET-CT data for radiotherapy planning: what are we looking for? Radiother Oncol 2010; 96: 277-279.
19. Coffey M, Vaandering A. Patient setup for PET/CT acquisition in radiotherapy planning. Radiother Oncol 2010; 96: 298-301.
20. Covens P, Berus D, Vanhavere F et al. The introduction of automated dispensing and injection during PET procedures: a step in the optimisation of extremity doses and whole-body doses of nuclear medicine staff. Radiat Prot Dosimetry 2010; 140: 250-258.
21. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature- based evidence as of September 2006. J Nucl Med 2007; 48 (Suppl 1): 78S-88S.
22. Daisne JF, Sibomana M, Bol A et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 2003; 69: 247-250.
23. Evans PM. Anatomical imaging for radiotherapy. Phys Med Biol 2008; 53: R151-R191.
24. Frings V, de Langen AJ, Smit EF et al. Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med 2010; 51: 1870-1877.
25. Geets X, Lee JA, Bol A et al. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007; 34: 1427-1438.
26. Geworski L, Knoop BO, de Witt M et al. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2001; 43: 635-639.
27. Geworski L, Reiners C. Qualitätsprüfung nuklearmedizinischer Messsysteme: Konstanzprüfung. In: Empfehlungen zur Qualitätskontrolle in der Nuklearmedizin- Klinik und Messtechnik. Geworski L, Lottes G, Reiners Chr, Schober O (eds). Stuttgart: Schattauer 2003; 217-289.
28. Gregoire V, Chiti A. PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool? Radiother Oncol 2010; 96: 275-276.
29. Grgic A, Ballek E, Fleckenstein J et al. Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer. Eur J Nucl Med Mol Imaging 2011; 38: 856-864.
30. Grgic A, Nestle U, Schaefer-Schuler A et al. FDGPET- based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning-- an intraindividual comparison. Int J Radiat Oncol Biol Phys 2009; 73: 103-111.
31. Hamacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
32. Hatt M, Cheze le Rest C, Turzo A et al. A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans Med Imaging 2009; 28: 881-893.
33. Hill DL, Batchelor PG, Holden M et al. Medical image registration. Phys Med Biol 2001; 46: R1-R45.
34. Hoetjes NJ, van Velden FH, Hoekstra OS et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol Imaging 2010; 37: 1679-1687.
35. Hofheinz F, Pötzsch C, Oehme L et al. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin 2012: 51: 9-16.
36. Hurkmans CW, van Lieshout M, Schuring D et al. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (Radiosurgery Or Surgery for operable Early stage (Stage 1A) non-small-cell Lung cancer [ROSEL] Study). Int J Radiat Oncol Biol Phys 2010; 80: 918-927.
37. IEC 61223-2-6: Evaluation and routine testing in medical imaging departments, Part 2-6: Constancy tests - Imaging performance of computed tomography X-ray equipment, 2006.
38. IEC 61223-3-5: Evaluation and routine testing in medical imaging departments, Part 3-5: Acceptance tests - Imaging performance of computed tomography X-ray equipment, 2004.
39. Kearns WT, Urbanic JJ, Hampton CJ et al. Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy. J Appl Clin Med Phys 2008; 9: 2763.
40. Kessler RM, Ellis Jr JR, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984; 8: 514-522.
41. Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/ computed tomography scanners. Semin Nucl Med 2003; 33: 166-179.
42. King MA, Long DT, Brill AB. SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size. Med Phys 1991; 18: 1016-1024.
43. Kotzerke J, Oehme L, Lindner O et al. Positron emission tomography 2008 in Germany - results of the query and current status. Nuklearmedizin 2010; 49: 58-64.
44. Krause BJ, Beyer T, Bockisch A et al. FDG-PET/CT in oncology. German Guideline. Nuklearmedizin 2007; 46: 291-301.
45. Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol 2010; 96: 302-307.
46. Ling CC, Humm J, Larson Amols H et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiol Oncol Biol Phys 2000; 47: 551-560.
47. Lockhart CM, MacDonald LR, Alessio AM et al. Quantifying and reducing the effect of calibration error on variability of PET/CT standardized uptake value measurements. J Nucl Med 2011; 52: 218-224.
48. Lonsdale MN, Beyer T. Dual-Modality PET/CT instrumentation - Today and tomorrow. Eur J Radiol 2010; 73: 452-460.
49. MacManus M, Nestle U, Rosenzweig KE et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009; 91: 85-94.
50. Mantlik F, Hofmann M, Werner MK et al. The effect of patient positioning aids on PET quantification in PET/MR imaging. Eur J Nucl Med Mol Imaging 2011; 38: 920-929.
51. Mutic S, Palta JR, Butker EK et al. Quality assurance for computed-tomography simulators and the computed tomography-simulation process: Report of the AAPM Radiation Therapy Committee Task Group No. 66. Med Phys 2003; 30: 2762-2792.
52. Nehmeh SA, El-Zeftawy H, Greco C et al. An iterative technique to segment PET lesions using a Monte Carlo based mathematical model. Med Phys 2009; 36: 4803-4809.
53. Nehmeh SA, Erdi YE, Meirelles GS et al. Deep-inspiration breath-hold PET/CT of the thorax. J Nucl Med 2007; 48: 22-26.
54. NEMA. DICOM Supplement 12, Addendum to part 3, positron emission tomography image objects, Final Text, 9 June 1996, http://dicom.nema.org/
55. NEMA. DICOM, Part 10, Media Storage and File Format for Media Interchange, 2008, http://dicom.nema.org
56. NEMA. DICOM, Part 3, Information Object Definitions, 2008, http://dicom.nema.org
57. NEMA. DICOM, Supplement 11, Addendum to part 3, Radiotherapy Objects, Final Text, 29 April 1997, http://dicom.nema.org/
58. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006; 81: 209-225.
59. Nestle U, Kremp S, Schaefer-Schuler A et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 2005; 46: 1342-1348.
60. Nestle U, Schaefer-Schuler A, Kremp S et al. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with nonsmall cell lung cancer. Eur J Nucl Med Mol Imaging 2007; 34: 453-462.
61. Nestle U, Weber W, Hentschel M et al. Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol 2009; 54: R1-R25.
62. Nevinny-Stickel M, Sweeney RA, Bale RJ et al. Reproducibility of patient positioning for fractionated extracranial stereotactic radiotherapy using a double-vacuum technique. Strahlenther Onkol 2004; 180: 117-122.
63. Otani Y, Fukuda I, Tsukamoto N et al. A comparison of the respiratory signals acquired by different respiratory monitoring systems used in respiratory gated radiotherapy. Med Phys 2010; 37: 6178-6186.
64. Pakbiers MTW, Kemerink GJ. Radiation exposure as a result of PET/CT. In: Radiation Dosimetry in Medicine: State of the Art in 2007. Vynckier S, Bos JJ, Lammertsma AA, Heijmen BJM, Zweers D (eds). Proceedings Fifth NCS Lustrum. Delft, The Netherlands: NCS 2007; 51-60.
65. Pan T, Sun X, Luo D. Improvement of the cine-CT based 4D-CT imaging. Med Phys 2007; 34: 4499-4503.
66. Paulino AC, Johnstone PA. FDG-PET in radio - therapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys 2004; 59: 4-5.
67. Pham DL, Xu C, Prince JL. Current methods in medical image segmentation. Ann Rev Biomed Eng 2000; 2: 315-337.
68. Pietrzyk U. Does PET/CT render software registration obsolete? Nuklearmedizin 2005; 44 (Suppl 1): S13-S17.
69. Rapisarda E, Bettinardi V, Thielemans K et al. Image-based point spread function implementation in a fully 3D OSEM reconstruction algorithm for PET. Phys Med Biol 2010; 55: 4131-4151.
70. Sattler B, Lee JA, Lonsdale M et al. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol 2010; 96: 288-297.
71. Schaefer A, Kremp S, Hellwig D et al. A contrastoriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging 2008; 35: 1989-1999.
72. Seierstad T, Stranden E, Bjering K et al. Doses to nuclear technicians in a dedicated PET/CT centre utilising 18F fluorodeoxyglucose (FDG). Radiat Prot Dosimetry 2007; 123: 246-249.
73. Skerl D, Likar B, Fitzpatrick JM et al. Comparative evaluation of similarity measures for the rigid registration of multi-modal head images. Phys Med Biol 2007; 52: 5587-5601.
74. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med 2004; 45 (Suppl 1): 36S-45S.
75. Söhn M, Weinmann M, Alber M. Intensity-modulated radiotherapy optimization in a quasi-periodically deforming patient model. Int J Radiat Oncol Biol Phys 2009; 75: 906-914.
76. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumour imaging. J Nucl Med 2007; 48: 932-945.
77. Souvatzoglou M, Bengel F, Busch R et al. Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET. Eur J Nucl Med Mol Imaging 2007; 34: 1991-2000.
78. Stergar H, Krause BJ, Eschmann SM et al. Lesion concordance, image quality and artefacts in PET/ CT: results of a multicenter study. Nuklearmedizin 2010; 49: 129-137.
79. Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET/CT data. Radiother Oncol 2010; 96: 317-324.
80. Thorwarth D, Schaefer A. Functional target volume delineation for radiation therapy on the basis of positron emission tomography and the correlation with histopathology. Q J Nucl Med Mol Imaging 2010; 54: 490-499.
81. Townsend DW, Carney JPJ, Yap JT et al. PET/CT today and tomorrow. J Nucl Med 2004; 45 (1 Suppl): 4S-14S.
82. Townsend DW. Multimodality imaging of structure and function. Phys Med Biol 2008; 53: R1-R39.
83. Van Baardwijk A, Bosmans G, Boersma L et al. PETCT- based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumour and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007; 68: 771-778.
84. Van Dalen JA, Hoffmann AL, Dicken V et al. A novel iterative method for lesion delineation and volumetric quantification with FDG PET. Nucl Med Commun 2007; 28: 485-493.
85. Vanderhoek M, Perlman SB, Jeraj R. Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med 2012; 53: 4-11.
86. Van Lin EN, van der Vight L, Huizenga H et al. Setup improvement in head and neck radiotherapy using a 3D off-line EPID-based correction protocol and a customised head and neck support. Radiother Oncol 2003; 68: 137-148.
87. Vogel WV, Oyen WJ, Barentsz JO et al. PET/CT: panacea, redundancy, or something in between? J Nucl Med 2004; 45 (Suppl 1): 15S-24S.
88. Vogel WV, Schinagl DA, Van Dalen JA et al. Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area. Q J Nucl Med Mol Imaging 2008; 52: 74-83.
89. Wanet M, Lee JA, Weynand B et al. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens. Radiother Oncol 2011; 98: 117-125.
90. Weigert M, Pietrzyk U, Muller S et al. Whole-body PET/CT imaging: combining software- and hardware- based co-registration. Z Med Phys 2008; 18: 59-66.